Driving Innovation in Cardiometabolic Drug Development
Meet ChemPartner at the Cardiometabolic Networking Summit 2025, where leading experts in diabetes, obesity, and cardiovascular drug discovery come together to share insights and forge collaborations. Our team is ready to discuss how our integrated discovery and preclinical platforms can support your cardiometabolic research—from target validation to IND-enabling studies.